Emulate

Boston, MA · Founded 2013 · Privately Held (backing)

Developer of organ-on-a-chip technology designed to predict human response with greater precision and detail than other experimental testing methods. Emulate is based in Boston, MA and was founded in 2013. It was valued at $140 million at its later-stage round in Mar 2024, the last priced event on record. It has raised $278 million across 7 recorded rounds; the latest was a $57.5 million later-stage round in Aug 2021.

PMV mark · valuation
$140.0M
Oct 2026
Priced at
its later-stage round
Mar 2024
Total raised
$278.4M
Last round
Later Stage VC
Aug 2021

Who backs Emulate?

33 investors
InvestorType
Alumni VenturesVenture capital
Founders FundVenture capital
United States Department of War—
Qiming Venture PartnersVenture capital
CSC UpShot VenturesVenture capital
Labcorp Venture FundVenture capital
ATEL Capital GroupAsset manager
Perceptive AdvisorsHedge fund
Harvard UniversityOther
SciFi VCVenture capital
+ 23 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Emulate investors

33 investors are on record for Emulate, including Alumni Ventures, Founders Fund, United States Department of War and Qiming Venture Partners. By type, the record holds 8 venture capital firms and 1 family office. The later-stage round in Aug 2021 drew 7 investors.

Free account
More of Emulate with a free account
  • ·The complete investor list: 33 names
  • ·Watch Emulate: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 33 firms already write checks for companies like Emulate. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View